Song Han Selected Research

Glucose (Dextrose)

1/2023	Activin A alleviates neuronal injury through inhibiting cGAS-STING-mediated autophagy in mice with ischemic stroke.
10/2022	EphA4 regulates white matter remyelination after ischemic stroke through Ephexin-1/RhoA/ROCK signaling pathway.
2/2021	[Acute cerebral ischemia-induced down-regulation of Sirt3 protein expression contributes to neuronal injury via damaging mitochondrial function].
1/2020	IL-17A Neutralization Improves the Neurological Outcome of Mice With Ischemic Stroke and Inhibits Caspase-12-Dependent Apoptosis.
12/2019	Hypoxia conditioning enhances neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia in vitro.
7/2019	Interleukin-17A-mediated alleviation of cortical astrocyte ischemic injuries affected the neurological outcome of mice with ischemic stroke.
1/2019	IL-17A-Mediated Excessive Autophagy Aggravated Neuronal Ischemic Injuries via Src-PP2B-mTOR Pathway.
5/2018	cPKCγ-Modulated Sequential Reactivation of mTOR Inhibited Autophagic Flux in Neurons Exposed to Oxygen Glucose Deprivation/Reperfusion.
1/2018	cPKCγ alleviates ischemic injury through modulating synapsin Ia/b phosphorylation in neurons of mice.
12/2017	cPKCγ-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Song Han Research Topics

Disease

51	Neoplasms (Cancer) 03/2024 - 02/2004
20	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 01/2012
18	Ischemic Stroke 01/2023 - 10/2013
16	Infarction (Infarctions) 01/2023 - 05/2011
14	Inflammation (Inflammations) 03/2024 - 06/2008
14	Wounds and Injuries (Trauma) 01/2023 - 05/2011
14	Hypoxia (Hypoxemia) 12/2019 - 08/2005
12	Infections 04/2024 - 05/2014
11	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 12/2015
11	Ischemia 10/2023 - 12/2007
10	Glioma (Gliomas) 01/2021 - 06/2013
9	Epilepsy (Aura) 01/2023 - 01/2013
8	Stroke (Strokes) 01/2023 - 10/2015
7	Brain Ischemia (Cerebral Ischemia) 01/2022 - 03/2012
6	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2011
6	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 07/2008
5	Pain (Aches) 11/2023 - 10/2009
5	Adenocarcinoma 09/2023 - 01/2013
5	Seizures (Absence Seizure) 01/2023 - 10/2013
5	Neuroinflammatory Diseases 11/2022 - 01/2017
5	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2016
4	Body Weight (Weight, Body) 02/2021 - 07/2009
4	Hyperalgesia 10/2020 - 10/2009
4	Brain Injuries (Brain Injury) 06/2018 - 05/2011
4	Pancreatitis 01/2017 - 07/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 12/2020
3	Demyelinating Diseases (Demyelinating Disease) 09/2023 - 01/2021
3	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 09/2012
3	Carcinogenesis 01/2023 - 02/2020
3	Multiple Sclerosis 11/2022 - 05/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2017
3	Diabetes Mellitus 01/2022 - 09/2014
3	Febrile Seizures (Febrile Seizure) 10/2018 - 08/2015
3	Hyperthermia 11/2017 - 10/2013
3	Fibrosis (Cirrhosis) 10/2015 - 07/2013
3	Edema (Dropsy) 09/2014 - 01/2012
2	Adenocarcinoma of Lung 03/2024 - 01/2022
2	Bites and Stings (Sting) 01/2024 - 01/2023
2	Cachexia 12/2023 - 02/2020
2	Weight Loss (Weight Reduction) 12/2023 - 02/2020
2	Hypersensitivity (Allergy) 11/2023 - 01/2021
2	Intervertebral Disc Degeneration 11/2023 - 01/2023
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2023 - 06/2020
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

47	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2005
18	Oxygen (Dioxygen)IBA 01/2023 - 02/2012
17	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2013
15	MicroRNAs (MicroRNA)IBA 11/2023 - 03/2012
11	Messenger RNA (mRNA)IBA 02/2024 - 08/2007
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2018
7	RNA (Ribonucleic Acid)IBA 12/2023 - 02/2004
7	CytokinesIBA 09/2023 - 11/2008
7	Protein Kinase CIBA 01/2018 - 06/2006
7	ApelinIBA 01/2017 - 08/2007
6	Peptides (Polypeptides)IBA 01/2019 - 07/2008
5	Kv1.3 Potassium ChannelIBA 11/2022 - 07/2008
5	LigandsIBA 01/2022 - 01/2013
5	Long Noncoding RNAIBA 01/2021 - 01/2017
4	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 08/2007
4	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 05/2021 - 11/2017
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2017
4	InterleukinsIBA 07/2019 - 10/2016
4	Protein Isoforms (Isoforms)IBA 01/2018 - 06/2006
3	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 02/2004
3	GTP Phosphohydrolases (GTPases)IBA 03/2024 - 08/2014
3	InflammasomesIBA 09/2023 - 01/2020
3	Circular RNAIBA 02/2023 - 01/2021
3	ChromatinIBA 01/2023 - 01/2022
3	Crystallins (Crystallin)IBA 01/2022 - 12/2011
3	Sitagliptin Phosphate (Januvia)FDA Link 05/2021 - 01/2017
3	Immune Checkpoint InhibitorsIBA 04/2021 - 12/2020
3	InterferonsIBA 01/2021 - 12/2015
3	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 04/2013
3	Therapeutic UsesIBA 01/2021 - 08/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 01/2013
3	salicylhydroxamic acid (SHAM)IBA 10/2020 - 08/2013
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2020 - 08/2007
3	Caspase 3 (Caspase-3)IBA 01/2020 - 11/2015
3	Conditioned Culture MediaIBA 12/2019 - 01/2017
3	vitexinIBA 06/2018 - 12/2015
3	Remifentanil (Ultiva)FDA Link 01/2018 - 10/2009
3	Small Interfering RNA (siRNA)IBA 12/2017 - 09/2012
3	Propofol (Diprivan)FDA LinkGeneric 01/2017 - 10/2009
3	Beclin-1IBA 12/2016 - 07/2014
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016 - 11/2012
2	ChemokinesIBA 03/2024 - 09/2023
2	AcidsIBA 01/2024 - 01/2016
2	EnzymesIBA 01/2024 - 01/2019
2	Neuroprotective AgentsIBA 11/2023 - 12/2019
2	Matrix Metalloproteinases (MMPs)IBA 11/2023 - 08/2006
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 09/2023 - 01/2020
2	activin AIBA 01/2023 - 01/2021
2	Histone ChaperonesIBA 01/2023 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2018

Therapy/Procedure

28	Therapeutics 03/2024 - 07/2008
3	Induced Hyperthermia (Thermotherapy) 01/2017 - 10/2013
3	Ligation 12/2015 - 09/2014
2	Conservative Treatment 08/2023 - 08/2014
2	Aftercare (After-Treatment) 08/2023 - 05/2014